Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention
Andrew Mujugira(Makerere University), James D. Campbell(Centers for Disease Control and Prevention), Jairam R. Lingappa(University of Namur), Allan Ronald(University of Namur), James Kiarie(World Health Organization), Jonathan Wangisi(The AIDS Support Organization), Carey Farquhar(University of Washington), Susan Morrison, Elizabeth A. Bukusi(University of California, San Francisco), Elly Katabira(University of Namur), Nelly Mugo(University of Washington), Lisa Ondrejcek, Heena Dinesh Shah(University of Washington), Grace John‐Stewart(Washington State Department of Health), Linda Barnes(University of Namur), Robert W. Coombs(University of Namur), Patrick Ndase, Lara Kidoguchi, Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Edwin Were(University of Namur), Jordan W. Tappero, Jennifer Revall, Connie Celum(University of Washington), Craig R. Cohen(University of Namur), Elioda Tumwesigye, Dana Panteleeff, Charlotte Ingram(South African National Blood Service), Meighan Krows, Kenneth H. Fife(Indiana University – Purdue University Indianapolis)
Cited by 92
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817